Related Experiment Videos

Screening and treatment of infections caused by resistant enterococci

D J Herman¹, D N Gerding

¹Department of Medicine, Veterans Affairs Medical Center, Minneapolis, Minnesota.

Antimicrobial Agents and Chemotherapy

|February 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021.

Antimicrobial agents and chemotherapy·2023

Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016.

Anaerobe·2020

U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.

Antimicrobial agents and chemotherapy·2019

Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Journal of clinical microbiology·2016

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.

The Journal of antimicrobial chemotherapy·2015

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Antimicrobial agents and chemotherapy·2015

See all related articles